Stay up to date
Subscribe to our newsletter to stay updated on our latest insights, products and promotions. We promise not to clog up your in-box.
06-26-010kU
RiboGrip® RNase Inhibitor (220 U/µL) is an in silico-designed protein-based ribonuclease inhibitor, which inactivates RNase A, RNase B and RNase C.
RiboGrip® RNase Inhibitor (220 U/µl) is an in silico-designed protein-based ribonuclease inhibitor, which inactivates RNase A, RNase B and RNase C.
RiboGrip® inhibits the activity of ribonuclease A by non-covalently binding in a non-competitive mode at a ratio of 1:1. It is primarily used to prevent RNA degradation by contaminating RNases in various assays that use RNA sample materials, such as first strand cDNA synthesis, RT-(q)PCR, RT-LAMP, etc.
RiboGrip® also includes a genetic modification – Stability TAG – Solis BioDyne’s proprietary and patented polypeptide stabilisation technology [1]. Stability TAG makes RiboGrip® extremely tolerant to higher temperatures and enables room temperature shipping as well as effective use in assays requiring high incubation temperatures. Demonstrated through our in-house testing where RiboGrip® retains full activity after 1 hour incubation at 60 °C.
Preventing RNA degradation in variety of applications including:
Storage: -20ºC. Temporary storage for up to 1 month at room temperature has no detrimental effects on the quality of the reagents.
Shipping: Room temperature
Subscribe to our newsletter to stay updated on our latest insights, products and promotions. We promise not to clog up your in-box.

"*" indicates required fields
Sending...
